Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Valsartan and Hydrochlorothiazide Dispersible Tablets

Approval Number

国药准字H20090282

Company鲁南贝特制药有限公司

Registration Date

May 25, 2023

Drug Information

Generic Name

缬沙坦氢氯噻嗪分散片

Dosage Form

片剂

Strength

80/12.5mg:每片含缬沙坦80mg,氢氯噻嗪12.5mg

Drug Type

化学药品

Registration Date

May 25, 2023

Company Information

Applicant Company

Company Name鲁南贝特制药有限公司

Company Address

山东省临沂市红旗路209号

Manufacturing Company

Company Name鲁南贝特制药有限公司

Company Address

山东省临沂市银雀山路243号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy